Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Population-based Study of Risk of Acute Kidney Injury With Levetiracetam

    Population-based Study of Risk of Acute Kidney Injury With Levetiracetam

    FromClinical Journal of the American Society of Nephrology (CJASN)

    Start listeningView podcast show

    Population-based Study of Risk of Acute Kidney Injury With Levetiracetam

    FromClinical Journal of the American Society of Nephrology (CJASN)

    ratings:
    Length:
    2 minutes
    Released:
    Dec 11, 2018
    Format:
    Podcast episode

    Description

    In this podcast, Dr. Kevin Yau discusses his article, "Population-based Study of Risk of Acute Kidney Injury With Levetiracetam" on behalf of his co-authors.
    Released:
    Dec 11, 2018
    Format:
    Podcast episode

    Titles in the series (100)

    Clinical Journal of the American Society of Nephrology (CJASN) publishes high quality research relevant to clinical nephrology. Now one of the most widely-read and referenced kidney journals, physicians read CJASN to learn about the most important advances in clinical and translational research in nephrology.